Free Stock Screener
Load Save Create a watchlist Help| Symbol | Company | Exchange | Industry | Market cap | EBITDA | P/E | EV/EBITDA | Debt/Equity | Average volume | Institutional ownership | Earnings date | Price | Performance today |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NONOF | Novo Nordisk A/S | OTC | Biotechnology | $294.46B | kr77.649B | 38.21 | 27.54 | 1.75 | 49.546k | 41.07% | N/A | $131.54 | +0.00% |
| NVO | Novo Nordisk | NYSE | Biotechnology | $293.86B | N/A | 55.20 | N/A | N/A | 4.944M | 8.30% | 6 Nov 2024 | $135.23 | +4.20% |
| NOVC | Novo Nordisk A/S | XETRA | Biotechnology | $276.66B | N/A | 37.82 | 3.35 | N/A | 83.976k | N/A | N/A | €182.98 | -0.71% |
| CSL | CSL Limited | ASX | Biotechnology | $96.86B | $3.325B | 36.66 | 28.24 | 0.96 | 698.660k | 33.93% | N/A | AUD$301.66 | +0.60% |
| CSLLY | CSL Ltd. | OTC | Biotechnology | 94.78B$ | $3.325B | 47.73 | 29.07 | 0.94 | 23.214k | 0.08% | N/A | $100.86 | -0.06% |
| REGN | Regeneron Pharmaceuticals, Inc. | NASDAQ | Biotechnology | $81.68B | $4.548B | 28.31 | 26.69 | 0.27 | 499.031k | 88.20% | 31 Oct 2024 | $1,141.45 | +0.45% |
| MRNA | Moderna Inc | NASDAQ | Biotechnology | $80.27B | -$4.11 | N/A | N/A | 0.33 | 5.181M | 64.21% | 31 Oct 2024 | $79.51 | +0.29% |
| VRTX | Vertex Pharmaceuticals, Inc. | NASDAQ | Biotechnology | $79.58B | $4.629B | N/A | 16.91 | 0.29 | 1.018M | 94.14% | 4 Nov 2024 | $474.74 | +0.84% |
| RGO | Regeneron Pharmaceuticals, Inc. | XETRA | Biotechnology | $79.24B | N/A | 16.40 | 11.43 | N/A | 54.000 | N/A | N/A | €766.50 | +0.07% |
| VX1 | Vertex Pharmaceuticals Incorporated | XETRA | Biotechnology | $75.52B | $3.277B | 35.32 | 21.86 | 0.33 | 628.000 | 94.14% | N/A | €420.70 | -1.50% |
| BNTX | BioNTech SE | NASDAQ | Biotechnology | $45.15B | €8.298B | N/A | 1.26 | 0.14 | N/A | 15.47% | 4 Nov 2024 | $99.27 | -1.35% |
| ALXN | Alexion Pharmaceuticals Inc. | NASDAQ | Biotechnology | $40.34B | $3.180B | 58.49 | N/A | 1.50 | 0.000 | 88.27% | N/A | $183.08 | +2.02% |
| 22UA | Biontech Se Spon. Adrs 1 | XETRA | Biotechnology | $40.09B | N/A | 4.05 | 1.78 | N/A | 32.965k | N/A | N/A | €88.80 | -1.06% |
| AXP | Alexion Pharmaceuticals, Inc. | XETRA | Biotechnology | $40.02B | $3.263B | 4.12 | 12.17 | 8.31 | 0.000 | 88.27% | N/A | €153.90 | +0.72% |
| WXXWY | Wuxi Biologics (Cayman), Inc. | OTC | Biotechnology | $30.08B | ¥4.599B | 22.98 | 43.09 | 0.35 | 62.364k | 0.02% | N/A | $2.85 | +4.40% |
| 2269 | WuXi Biologics (Cayman) Inc. | HKSE | Biotechnology | $29.86B | ¥4.599B | 11.67 | 42.78 | 12.40 | 47.134M | 46.32% | N/A | HKD$11.68 | +3.36% |
| GMAB | Genmab | NASDAQ | Biotechnology | $29.44B | N/A | 7.09 | N/A | N/A | N/A | 6.03% | 6 Nov 2024 | $26.93 | -2.07% |
| ALNY | Alnylam Pharmaceuticals Inc | NASDAQ | Biotechnology | $29.16B | $157.972M | N/A | 216.73 | -18.36 | N/A | 94.71% | 31 Oct 2024 | $261.91 | +2.22% |
| GNMSF | Genmab A/S | OTC | Biotechnology | $29.15B | kr3.717B | 26.80 | 52.56 | 0.11 | 2.278k | 53.66% | N/A | $266.07 | +0.00% |
| DUL | Alnylam Pharmaceuticals, Inc. | XETRA | Biotechnology | $28.25B | -$749.49 | N/A | N/A | 5.19 | 0.000 | 100.00% | N/A | €227.20 | +1.20% |
| SGEN | Seagen Inc | NASDAQ | Biotechnology | $23.02B | -$666.67 | N/A | N/A | 1.33 | 0.000 | 91.25% | N/A | $228.86 | -0.02% |
| GE9 | Genmab A/S | XETRA | Biotechnology | 22.10B$ | kr4.763B | 68.12 | 29.90 | 0.11 | 0.000 | 52.69% | N/A | €331.00 | +0.00% |
| ARGX | Argen X SE | NASDAQ | Biotechnology | $21.57B | N/A | N/A | N/A | N/A | 536.800k | 63.21% | 31 Oct 2024 | $537.43 | +0.45% |
| BGNE | BeiGene Ltd | NASDAQ | Biotechnology | $21.42B | -$883.15 | N/A | N/A | 0.64 | N/A | 63.15% | 11 Nov 2024 | $211.15 | +6.80% |
| 6160 | BeiGene, Ltd. | HKSE | Biotechnology | $21.36B | -$1.86 | N/A | N/A | 0.64 | 1.077M | 28.59% | N/A | HKD$118.30 | -5.44% |
| IMMU | Immunomedics, Inc. | NASDAQ | Biotechnology | $20.31B | N/A | N/A | N/A | N/A | 0.000 | 81.31% | N/A | $87.86 | +0.05% |
| BMRN | Biomarin Pharmaceutical Inc. | NASDAQ | Biotechnology | $19.51B | $298.308M | 62.80 | 58.47 | 0.38 | 2.086M | 98.81% | 30 Oct 2024 | $84.78 | -0.08% |
| ARGX | argenx SE | EURONEXT | Biotechnology | $19.43B | -$850.16 | N/A | N/A | 0.11 | 68.028k | 32.54% | N/A | €485.40 | -1.30% |
| BM8 | BioMarin Pharmaceutical Inc. | XETRA | Biotechnology | $18.51B | $109.156M | 183.67 | 146.96 | 0.41 | 5.000 | 98.81% | N/A | €81.02 | -0.12% |
| INCY | Incyte Corp. | NASDAQ | Biotechnology | $18.31B | $120.890M | 166.13 | 89.90 | 0.31 | N/A | 96.09% | 5 Nov 2024 | $63.13 | +0.00% |
| RPRX | Royalty Pharma plc | NASDAQ | Biotechnology | $17.52B | $942.794M | 18.40 | 19.27 | 0.62 | 4.362M | 63.29% | 7 Nov 2024 | $27.78 | -1.00% |
| NVZMY | Novozymes A/S | OTC | Biotechnology | $14.61B | kr5.488B | 62.85 | 19.25 | 0.98 | 10.372k | 0.05% | N/A | $69.10 | -0.20% |
| UCB | UCB SA | EURONEXT | Biotechnology | $14.12B | €1.479B | 57.43 | 10.69 | 0.73 | 233.690k | 38.68% | N/A | €162.75 | +0.99% |
| TECH | Bio-Techne Corp | NASDAQ | Biotechnology | $13.63B | $358.872M | 68.68 | 32.58 | 0.31 | 1.271M | 95.84% | 31 Oct 2024 | $73.49 | -0.39% |
| UTHR | United Therapeutics Corp | NASDAQ | Biotechnology | $12.63B | $1.324B | 14.99 | 9.95 | 0.20 | N/A | 100.00% | 30 Oct 2024 | $346.19 | +1.09% |
| MYOK | MyoKardia, Inc. | NASDAQ | Biotechnology | $11.99B | N/A | N/A | N/A | N/A | 0.000 | 100.00% | N/A | $224.91 | +0.05% |
| NBIX | Neurocrine Biosciences, Inc. | NASDAQ | Biotechnology | $11.46B | $569.400M | 35.41 | 24.93 | 0.46 | N/A | 97.75% | 31 Oct 2024 | $121.47 | +1.99% |
| XLRN | Acceleron Pharma Inc | NASDAQ | Biotechnology | $10.93B | -$251.26 | 0.00 | N/A | 1.10 | 0.000 | 90.60% | N/A | $178.75 | -0.52% |
| 1177 | Sino Biopharmaceutical Limited | HKSE | Biotechnology | $10.79B | ¥5.166B | 32.37 | 13.44 | 0.67 | 47.879M | 14.13% | N/A | HKD$3.11 | -1.58% |
| SRPT | Sarepta Therapeutics Inc | NASDAQ | Biotechnology | $10.39B | -$509.08 | 171.19 | N/A | 2.80 | 1.372M | 84.59% | 6 Nov 2024 | $128.39 | +1.14% |
| RGEN | Repligen Corp. | NASDAQ | Biotechnology | $9.85B | $194.038M | N/A | 47.61 | 0.43 | N/A | 93.28% | 29 Oct 2024 | $143.40 | -2.25% |
| JAZZ | Jazz Pharmaceuticals plc | NASDAQ | Biotechnology | $9.69B | $1.204B | 16.74 | 8.96 | 2.05 | 2.883M | 97.33% | 6 Nov 2024 | $105.13 | -1.84% |
| LEGN | Legend Biotech Corp | NASDAQ | Biotechnology | $8.68B | -$354.91 | N/A | N/A | 0.48 | 962.165k | 32.08% | N/A | $49.75 | -0.10% |
| HALO | Halozyme Therapeutics Inc. | NASDAQ | Biotechnology | $7.70B | $306.646M | 22.75 | 22.01 | 19.68 | 2.284M | 96.60% | 4 Nov 2024 | $59.39 | +0.22% |
| ASND | Ascendis Pharma A/S | NASDAQ | Biotechnology | $7.06B | N/A | 0.00 | N/A | N/A | 296.403k | 100.00% | N/A | $112.93 | -1.59% |
| 2696.HK | Shanghai Henlius Biotech Inc | HKSE | Biotechnology | $7.01B | -¥255.02 | N/A | N/A | 2.12 | 749.094k | 32.03% | N/A | $23.15 | +0.22% |
| 6855.HK | Ascentage Pharma Grp Intl | HKSE | Biotechnology | $6.81B | -¥924.31 | N/A | N/A | 1.38 | 1.512M | 14.49% | N/A | $32.45 | -1.07% |
| 3759 | Pharmaron Beijing Co., Ltd. | HKSE | Biotechnology | $6.66B | ¥2.108B | 23.37 | 34.45 | 1.00 | 3.490M | 76.81% | N/A | HKD$9.32 | -0.53% |
| 1877 | Shanghai Junshi Biosciences Co., Ltd. | HKSE | Biotechnology | $6.35B | -¥1.51 | N/A | N/A | 0.55 | 766.533k | 33.64% | N/A | HKD$10.66 | +1.91% |
| ARNA | Arena Pharmaceuticals Inc | NASDAQ | Biotechnology | $6.16B | -$548.37 | 0.00 | N/A | 1.17 | 0.000 | 84.05% | N/A | $99.99 | +0.06% |
Sign up
